Pioneering Cord Blood Storage
CryoCord has firmly established itself as a pioneer in cord blood storage, combining innovation and reliability to deliver life-saving solutions. With over 70,000 samples preserved in its facility, it has earned parents’ trust as a dependable custodian of vital resources. Every sample is handled meticulously, reflecting commitment to quality, safety, and long-term viability.
From the moment a baby’s cord blood is collected, CryoCord’s highly trained personnel oversee the process with precision. Step-by-step protocols govern collection, transportation, processing, and storage, ensuring every sample remains uncontaminated and viable for future therapeutic use. The facility’s 10 Class-100 cleanrooms, fully compliant with ISO Class 5 standards, provide contamination-free conditions, while advanced monitoring systems track each sample around the clock. Families can be confident that their child’s cord blood is preserved under conditions aligned with global best practices.
Advanced AXP II technology further enhances stem cell harvest consistency, allowing families to benefit from high-quality samples. CryoCord also provides guidance to parents, offering clear instructions and support for collection procedures to minimize any risk of error. This combination of expertise, technology, and care sets CryoCord apart as a pioneer in cord blood preservation.
Accreditation and Operational Excellence
CryoCord sets the benchmark for technical and administrative excellence. It is the first in Malaysia to achieve cGMP (PIC/S) certification by the National Pharmaceutical Regulatory Agency (NPRA). This accreditation, aligned with AABB standards, validates the laboratory’s adherence to global best practices and its commitment to operational standards.
Operating under full licenses granted by the Ministry of Health Malaysia under the Private Healthcare Facilities and Services (PHFS) Act 1998, CryoCord complies with stringent healthcare protocols. Regular internal and external audits verify that all operational and administrative procedures meet international and local standards. Families can trust that each sample is stored under the highest quality and safety measures, giving them confidence in the reliability of the service.
CryoCord’s focus on operational excellence extends beyond certification. Every workflow is designed to minimise human error, including automated monitoring, barcode tracking, and redundancy systems to safeguard samples. Staff undergo continuous professional development, ensuring their knowledge of the latest techniques, technologies, and regulations is always up to date. This emphasis on professional expertise reinforces the company’s credibility and reliability.
Advanced Facilities and Scale
CryoCord’s laboratory is among the most advanced in Southeast Asia, housing 10 Grade B (ISO Class 5) cleanrooms and the largest Biosafety Level 2 (BSL-2) GMP facility. These purpose-built spaces maintain controlled conditions, ensuring the long-term viability of stored samples.
With over 70,000 samples cataloged and carefully monitored, CryoCord demonstrates both operational reliability and capacity to serve families for decades. The laboratory is equipped with automated alarm systems, backup power, and emergency contingency plans to ensure uninterrupted sample integrity even in unforeseen events. Families can trust that their child’s cord blood is safeguarded continuously.
CryoCord’s scale also allows it to accommodate a growing number of clients while maintaining individualized attention to each sample. The laboratory’s capacity, combined with meticulous cataloging and tracking, ensures that the company can reliably manage large volumes of samples without compromising quality. This balance of scale and precision is a cornerstone of CryoCord’s leadership in the field.
Process Transparency and Client Communication
Transparency is central to CryoCord’s operations. Every sample is documented meticulously, creating a clear chain of custody from collection to storage. Parents receive detailed reports and regular updates, providing visibility and reassurance that their child’s sample is handled responsibly.
CryoCord goes beyond documentation by offering guidance and educational resources to families. Parents are informed about the potential uses of cord blood, the science behind stem cell storage, and how to ensure proper collection. This open communication fosters confidence and empowers families to make informed decisions.
The company’s commitment to transparency also extends to innovation. Since 2022, CryoCord has been the first in Southeast Asia to offer induced pluripotent stem cells (iPSCs) storage derived from cord blood. These iPSCs provide an unlimited source of human cells for therapeutic purposes, offering potential in personalised medicine and regenerative therapies. By combining cutting-edge technology with clear, informative communication, CryoCord ensures families understand both the present and future possibilities of stem cell preservation.
Trusted Custodianship and Long-Term Reliability
CryoCord’s reputation rests on trust, professionalism, and long-term commitment. Families are assured that their child’s cord blood is handled responsibly, stored securely, and continuously monitored. Long-term relationships are fostered through consistent communication, transparent reporting, and dedicated operational oversight.
By integrating advanced facilities, rigorous protocols, innovative technologies, and transparent client communication, CryoCord exemplifies leadership in cord blood storage. Families are not only investing in safe storage, they are investing in the potential for future medical breakthroughs, peace of mind, and transformative healthcare opportunities. CryoCord continues to set the gold standard in cord blood preservation, delivering hope, security, and access to advanced therapies for generations to come.
